Cannabis Science Is Very Excited as the DEA Considers to Reschedule Marijuana/Cannabis
Reschedule Cannabis
Cannabis Science Is Very Excited as the DEA Considers to Reschedule Marijuana/Cannabis
I do not have a lot to add this personally so read the summary and click on to read the entire article.
Cannabis Science Is Very Excited as the DEA Considers to Reschedule Marijuana/Cannabis With a Landmark Decision as Early as Mid-Year, 2016 COLORADO SPRINGS, CO–(Marketwired – Apr 6, 2016) – Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today acknowledges and is very excited about the Landmark move with the Drug Enforcement Agencys (DEA) decision to review marijuanas federal drug classification as early as mid-2016. Rescheduling marijuana would ease restrictions on research across the country, while at the same time reducing penalties for marijuana offenses. Increased research capabilities could spur innovation and growth in the cannabis industry. To review the Huffington Post article please click here to read the article in its entirety. In a letter to the Senators; http://big.assets.huffingtonpost.com/dearesponse.pdf the Drug Enforcement Administration (DEA) is looking to decide on the reclassification of Marijuana by mid-year. For years, marijuana has shared the “Schedule I” classification with heroin and LSD, drugs with much higher rates of death and hospitalization for users. This classification also specifies the%
